The benefit of abciximab in percutaneous coronary revascularization is not device-specific

2000-05-01

The American Journal of Cardiology , Volume 85 - Issue 9 p. 1060- 1064

Additional Metadata
Persistent URL	doi.org/10.1016/S0002-9149(00)00696-2, hdl.handle.net/1765/56760
Journal	The American Journal of Cardiology
Organisation	Department of Cardiology
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Bhatt, D., Lincoff, M., Califf, R., Simoons, M., Tcheng, J., Brener, S., Wolski, K. E.& Topol, E. (2000). The benefit of abciximab in percutaneous coronary revascularization is not device-specific. The American Journal of Cardiology, 85(9), 1060–1064.https://doi.org/10.1016/S0002-9149(00)00696-2

Publication